JP5924984B2 - Trifluoromethylpyridinone compound and method for producing the same - Google Patents
Trifluoromethylpyridinone compound and method for producing the same Download PDFInfo
- Publication number
- JP5924984B2 JP5924984B2 JP2012048888A JP2012048888A JP5924984B2 JP 5924984 B2 JP5924984 B2 JP 5924984B2 JP 2012048888 A JP2012048888 A JP 2012048888A JP 2012048888 A JP2012048888 A JP 2012048888A JP 5924984 B2 JP5924984 B2 JP 5924984B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- trifluoromethyl
- pyridinone
- formula
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 Trifluoromethylpyridinone compound Chemical class 0.000 title claims description 48
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 26
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 22
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 claims description 12
- 239000011698 potassium fluoride Substances 0.000 claims description 11
- 235000003270 potassium fluoride Nutrition 0.000 claims description 11
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052802 copper Inorganic materials 0.000 claims description 9
- 239000010949 copper Substances 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- 238000005481 NMR spectroscopy Methods 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000004566 IR spectroscopy Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 150000005299 pyridinones Chemical group 0.000 description 5
- JHDCDEHVUADNKQ-UHFFFAOYSA-N 3-(trifluoromethyl)-1h-pyridin-2-one Chemical compound OC1=NC=CC=C1C(F)(F)F JHDCDEHVUADNKQ-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- WQULPNIRGWQPQQ-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-5-(trifluoromethyl)pyridin-2-one Chemical compound C1=CC(OC)=CC=C1CN1C(=O)C=CC(C(F)(F)F)=C1 WQULPNIRGWQPQQ-UHFFFAOYSA-N 0.000 description 3
- CMGFDWXMBSCUMD-UHFFFAOYSA-N 3,5-diiodo-1-methylpyridin-2-one Chemical compound CN1C=C(I)C=C(I)C1=O CMGFDWXMBSCUMD-UHFFFAOYSA-N 0.000 description 3
- XJANJBWJKFIUTI-UHFFFAOYSA-N 3-iodo-1-methyl-5,6,7,8-tetrahydroquinolin-2-one Chemical compound Cn1c2CCCCc2cc(I)c1=O XJANJBWJKFIUTI-UHFFFAOYSA-N 0.000 description 3
- VKNLXKRZDCJRAG-UHFFFAOYSA-N 3-iodo-1-methyl-6,7-dihydro-5H-cyclopenta[b]pyridin-2-one Chemical compound Cn1c2CCCc2cc(I)c1=O VKNLXKRZDCJRAG-UHFFFAOYSA-N 0.000 description 3
- RMGDJLOUEQWPOU-UHFFFAOYSA-N 3-iodo-1-methylpyridin-2-one Chemical compound CN1C=CC=C(I)C1=O RMGDJLOUEQWPOU-UHFFFAOYSA-N 0.000 description 3
- OOCFODFKYQJDFZ-UHFFFAOYSA-N 5-iodo-1-[(4-methoxyphenyl)methyl]pyridin-2-one Chemical compound COc1ccc(Cn2cc(I)ccc2=O)cc1 OOCFODFKYQJDFZ-UHFFFAOYSA-N 0.000 description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- 239000003905 agrochemical Substances 0.000 description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 3
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 3
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000008204 material by function Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FHUHWCJWXNYAMP-UHFFFAOYSA-N 1H-pyridin-2-one hydroiodide Chemical compound N1C(C=CC=C1)=O.I FHUHWCJWXNYAMP-UHFFFAOYSA-N 0.000 description 2
- AKSNZYAJXCFOSW-UHFFFAOYSA-N 3-iodo-1-[(4-methoxyphenyl)methyl]-5,6-dihydrobenzo[h]quinolin-2-one Chemical compound COc1ccc(Cn2c-3c(CCc4ccccc-34)cc(I)c2=O)cc1 AKSNZYAJXCFOSW-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 150000002390 heteroarenes Chemical class 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- QHMQWEPBXSHHLH-UHFFFAOYSA-N sulfur tetrafluoride Chemical compound FS(F)(F)F QHMQWEPBXSHHLH-UHFFFAOYSA-N 0.000 description 2
- 238000006692 trifluoromethylation reaction Methods 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- KCPDMRDHQWCYAK-UHFFFAOYSA-N 1-methyl-3-(trifluoromethyl)-5,6,7,8-tetrahydroquinolin-2-one Chemical compound Cn1c2CCCCc2cc(c1=O)C(F)(F)F KCPDMRDHQWCYAK-UHFFFAOYSA-N 0.000 description 1
- RXATZPCCMYMPME-UHFFFAOYSA-N 2-chloro-3-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=CN=C1Cl RXATZPCCMYMPME-UHFFFAOYSA-N 0.000 description 1
- JFZJMSDDOOAOIV-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)N=C1 JFZJMSDDOOAOIV-UHFFFAOYSA-N 0.000 description 1
- YWOWJQMFMXHLQD-UHFFFAOYSA-N 3-(trifluoromethyl)pyridin-2-amine Chemical compound NC1=NC=CC=C1C(F)(F)F YWOWJQMFMXHLQD-UHFFFAOYSA-N 0.000 description 1
- JTZSFNHHVULOGJ-UHFFFAOYSA-N 3-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=CN=C1 JTZSFNHHVULOGJ-UHFFFAOYSA-N 0.000 description 1
- BYRJSCNPUHYZQE-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-pyridin-2-one Chemical compound OC1=CC=C(C(F)(F)F)C=N1 BYRJSCNPUHYZQE-UHFFFAOYSA-N 0.000 description 1
- ZDJUNNCVIDKJAN-UHFFFAOYSA-N 5-iodo-1h-pyridin-2-one Chemical compound OC1=CC=C(I)C=N1 ZDJUNNCVIDKJAN-UHFFFAOYSA-N 0.000 description 1
- BLHCMGRVFXRYRN-UHFFFAOYSA-N 6-hydroxynicotinic acid Chemical compound OC(=O)C1=CC=C(O)N=C1 BLHCMGRVFXRYRN-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- AOWRAADERJYXOI-UHFFFAOYSA-N C1=C(C(F)(F)F)C(=O)N(C)C2=C1CCC2 Chemical compound C1=C(C(F)(F)F)C(=O)N(C)C2=C1CCC2 AOWRAADERJYXOI-UHFFFAOYSA-N 0.000 description 1
- ARGRITOUVGQGJQ-UHFFFAOYSA-N C1=CC(OC)=CC=C1CN1C(=O)C(C(F)(F)F)=CC2=C1C1=CC=CC=C1CC2 Chemical compound C1=CC(OC)=CC=C1CN1C(=O)C(C(F)(F)F)=CC2=C1C1=CC=CC=C1CC2 ARGRITOUVGQGJQ-UHFFFAOYSA-N 0.000 description 1
- FRVKYHINCSJCTI-UHFFFAOYSA-N CN1C=C(C(F)(F)F)C=C(C(F)(F)F)C1=O Chemical compound CN1C=C(C(F)(F)F)C=C(C(F)(F)F)C1=O FRVKYHINCSJCTI-UHFFFAOYSA-N 0.000 description 1
- SPTWVURHMGVELS-UHFFFAOYSA-N CN1C=C(I)C=C(C(F)(F)F)C1=O Chemical compound CN1C=C(I)C=C(C(F)(F)F)C1=O SPTWVURHMGVELS-UHFFFAOYSA-N 0.000 description 1
- QWRGLJHUJMVTDM-UHFFFAOYSA-N COC1=CC=C(C=C1)CN2CC=CC(=C2)C(F)(F)F Chemical compound COC1=CC=C(C=C1)CN2CC=CC(=C2)C(F)(F)F QWRGLJHUJMVTDM-UHFFFAOYSA-N 0.000 description 1
- 239000012028 Fenton's reagent Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 102000006239 metabotropic receptors Human genes 0.000 description 1
- 108020004083 metabotropic receptors Proteins 0.000 description 1
- GQJCAQADCPTHKN-UHFFFAOYSA-N methyl 2,2-difluoro-2-fluorosulfonylacetate Chemical compound COC(=O)C(F)(F)S(F)(=O)=O GQJCAQADCPTHKN-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VGGNVBNNVSIGKG-UHFFFAOYSA-N n,n,2-trimethylaziridine-1-carboxamide Chemical compound CC1CN1C(=O)N(C)C VGGNVBNNVSIGKG-UHFFFAOYSA-N 0.000 description 1
- ZCOGQSHZVSZAHH-UHFFFAOYSA-N n,n-dimethylaziridine-1-carboxamide Chemical compound CN(C)C(=O)N1CC1 ZCOGQSHZVSZAHH-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Description
本発明は、トリフルオロメチル基を有する新規なピリジノン化合物に関するものである。 The present invention relates to a novel pyridinone compound having a trifluoromethyl group.
医農薬や機能性材料にトリフルオロメチル基を導入することが、生理活性の向上あるいは材料物性の改良に資することは良く知られている。 It is well known that introduction of a trifluoromethyl group into a medical pesticide or a functional material contributes to an improvement in physiological activity or material properties.
従来種々のトリフルオロメチル化法が報告されているが、その殆どはπ電子の過剰なヘテロ環あるいは芳香環化合物にのみ適用可能であった。しかしながら、医農薬や機能性材料にはπ電子不足型ヘテロ芳香環化合物が重要な役割をしていることは周知の事実であり、当該化合物への簡便かつ効率的なトリフルオロメチル基導入法を開発することは重要な課題であった。 Various trifluoromethylation methods have been reported in the past, but most of them were applicable only to heterocyclic or aromatic ring compounds having an excess of π electrons. However, it is a well-known fact that π-electron deficient heteroaromatic compounds play an important role in medical pesticides and functional materials, and a simple and efficient method for introducing a trifluoromethyl group into such compounds is known. Developing was an important issue.
特許文献1では、トリフルオロメチル基を有するピリジノン環が代謝調節型受容体サブタイプの正のアロステリック因子として働き、不安神経症や統合失調症などの中枢神経系障害の予防に役立つことが報告されている。しかしながら、4位が水素原子以外であり、かつ3位にトリフルオロメチル基を有するピリジノン化合物に限られており、ヨウ化ピリジノンに銅塩とメチル 2,2−ジフルオロ−2−フルオロスルホニルアセテートと反応させることにより、トリフルオロメチル基の導入を行っている。 In Patent Document 1, it is reported that a pyridinone ring having a trifluoromethyl group works as a positive allosteric factor of a metabotropic receptor subtype and is useful for prevention of central nervous system disorders such as anxiety and schizophrenia. ing. However, it is limited to pyridinone compounds that are other than hydrogen atoms at the 4-position and have a trifluoromethyl group at the 3-position, and react with a copper salt and methyl 2,2-difluoro-2-fluorosulfonyl acetate on pyridinone iodide. In this way, the trifluoromethyl group is introduced.
例えば、非特許文献1では、2−アミノ−3−(トリフルオロメチル)ピリジンのアミノ基を硫酸水溶液中で亜硝酸ナトリウムを供することにより、ヒドロキシ基に変換して3−(トリフルオロメチル)ピリジン−2(1H)−オンを収率69%で得られたと開示されている。また、特許文献2では、2−クロロ−3−(トリフルオロメチル)ピリジンのクロロ基を酢酸中7日間還流することにより、ヒドロキシ基に変換して3−(トリフルオロメチル)ピリジン−2(1H)−オンを収率93%で得られたと開示されている(当該20頁、0057段落)。しかしながら、この方法では、反応時間が7日間も要することが問題である。さらに、トリフルオロメチル化された原料を入手する必要があった。 For example, in Non-Patent Document 1, an amino group of 2-amino-3- (trifluoromethyl) pyridine is converted to a hydroxy group by providing sodium nitrite in an aqueous sulfuric acid solution, thereby converting 3- (trifluoromethyl) pyridine. -2 (1H) -one is disclosed to be obtained in 69% yield. In Patent Document 2, the chloro group of 2-chloro-3- (trifluoromethyl) pyridine is converted into a hydroxy group by refluxing in acetic acid for 7 days to give 3- (trifluoromethyl) pyridine-2 (1H ) -One was disclosed to be obtained in 93% yield (20 pages, 0057 paragraph). However, this method has a problem that the reaction time takes 7 days. Furthermore, it was necessary to obtain a trifluoromethylated raw material.
特許文献3はFenton試薬を用いてピリジン−2(1H)−オンに直接的にトリフルオロメチル基を導入しており、基質が無保護のNH基を有していても反応する点で優れているが、収率が50%と中程度である(当該Ex.11)。また、この方法では3位のみにトリフルオロメチル基の導入が可能となっている。 Patent Document 3 is excellent in that a trifluoromethyl group is directly introduced into pyridin-2 (1H) -one using a Fenton reagent and the substrate reacts even if it has an unprotected NH group. However, the yield is about 50% (ex. 11). In this method, a trifluoromethyl group can be introduced only at the 3-position.
特許文献4は2−クロロ−5−(トリフルオロメチル)ピリジンのクロロ基を酢酸銀存在下酢酸中45時間還流することにより、ヒドロキシ基に変換して5−(トリフルオロメチル)ピリジン−2(1H)−オンを収率51%で得られたと開示されている(当該Ex.111のStepC)。140℃の高温下での反応を要し、かつ反応時間が45時間と長時間を要する点が課題であった。さらに、トリフルオロメチル化された原料を入手する必要があった。 In Patent Document 4, the chloro group of 2-chloro-5- (trifluoromethyl) pyridine is converted to a hydroxy group by refluxing in acetic acid for 45 hours in the presence of silver acetate to convert 5- (trifluoromethyl) pyridine-2 ( It is disclosed that 1H) -one was obtained in 51% yield (Step C of Ex. 111). The problem was that a reaction at a high temperature of 140 ° C. was required and a reaction time of 45 hours was required. Furthermore, it was necessary to obtain a trifluoromethylated raw material.
特許文献5は5−(カルボキシ)ピリジン−2(1H)−オンに、四フッ化イオウを作用させることにより5−(トリフルオロメチル)ピリジン−2(1H)−オンが得られることを開示しているが、四フッ化イオウは有毒であり汎用性がない。 Patent document 5 discloses that 5- (trifluoromethyl) pyridin-2 (1H) -one can be obtained by allowing sulfur tetrafluoride to act on 5- (carboxy) pyridin-2 (1H) -one. However, sulfur tetrafluoride is toxic and not versatile.
非特許文献2では5−(トリフルオロメチル)ピラン−(2H)−オンにヘキサメチルジシラザンとDBUを供し3日間撹拌することにより、収率16%で5−(トリフルオロメチル)ピリジン−2(1H)−オンが得られることを開示しているが、低収率である。 In Non-Patent Document 2, 5- (trifluoromethyl) pyran- (2H) -one is subjected to hexamethyldisilazane and DBU and stirred for 3 days to give 5- (trifluoromethyl) pyridine-2 in a yield of 16%. Although it discloses that (1H) -one is obtained, the yield is low.
非特許文献3にはピリジン環へのトリフルオロメチル基導入法が開示されているが、ピリジノン化合物に適用した例はない。 Non-Patent Document 3 discloses a method for introducing a trifluoromethyl group into a pyridine ring, but there is no example applied to a pyridinone compound.
医農薬や機能性材料にはπ電子不足型ヘテロ芳香環化合物が重要な役割を果たすことが知られており、当該化合物へ簡便かつ効率的にトリフルオロメチル基を導入する方法を開発することは重要な課題であった。本発明は、優れた医農薬中間体のピリジノン化合物であってトリフルオロメチル基を有する新規ピリジノン化合物を提供する。 Π-electron deficient heteroaromatic compounds are known to play an important role in medical pesticides and functional materials, and developing a simple and efficient method for introducing a trifluoromethyl group into the compound It was an important issue. The present invention provides a novel pyridinone compound having a trifluoromethyl group as an excellent pharmaceutical and agrochemical intermediate pyridinone compound.
本発明者らは鋭意検討を行った結果、新規のトリフルオロメチル基を有するピリジノン化合物を見出し、さらにヨウ化ピリジノン化合物、ハロゲン化銅、(トリフルオロメチル)トリメチルシランおよび塩類を用いることによって簡便かつ効率的に合成できることを見出した。 As a result of intensive studies, the present inventors have found a novel pyridinone compound having a trifluoromethyl group, and by using an iodinated pyridinone compound, copper halide, (trifluoromethyl) trimethylsilane and salts, We found that it can be synthesized efficiently.
すなわち、本発明は下記の式(1)〜(7)で表されるトリフルオロメチルピリジノン化合物に関するものである。
(1)トリフルオロメチル基を有するピリジノン化合物であって、下記式(1)〜(7)で表わされるトリフルオロメチルピリジノン化合物。
That is, the present invention relates to a trifluoromethylpyridinone compound represented by the following formulas (1) to (7).
(1) A trifluoromethylpyridinone compound having a trifluoromethyl group, which is represented by the following formulas (1) to (7).
(2) 下記式(8)〜(13)で表されるヨウ化ピリジノン化合物、ハロゲン化銅、(トリフルオロメチル)トリメチルシランおよび塩フッ化カリウム、フッ化セシウムおよびtert−ブトキシカリウムからなる群より選ばれる少なくとも1種の塩類を反応させることを特徴とする(1)に記載の式(1)〜(7)で表わされるトリフルオロメチルピリジノン化合物の製造方法。 (2) From the group consisting of a pyridinone iodide compound represented by the following formulas (8) to (13), copper halide, (trifluoromethyl) trimethylsilane and potassium chlorofluoride, cesium fluoride and tert-butoxypotassium A method for producing a trifluoromethylpyridinone compound represented by formulas (1) to (7) according to (1), wherein at least one selected salt is reacted.
発明者らはトリフルオロメチル基を有する新規のピリジノン化合物を見出し、当該ピリジノン化合物はヨウ化ピリジノン化合物、ハロゲン化銅、(トリフルオロメチル)トリメチルシランおよび塩類を用いた反応によって合成できることを見出した。 The inventors have found a novel pyridinone compound having a trifluoromethyl group, and have found that the pyridinone compound can be synthesized by a reaction using an iodinated pyridinone compound, copper halide, (trifluoromethyl) trimethylsilane and salts.
本発明のトリフルオロメチル基を有するピリジノン化合物は、優れた医農薬中間体および機能性材料原料であり、工業的にも有用である。本発明は、前記式(1)〜(7)で表わされるトリフルオロメチル基を有する新規ピリジノン化合物を提供する。 The pyridinone compound having a trifluoromethyl group of the present invention is an excellent intermediate for medical and agricultural chemicals and a functional material, and is industrially useful. The present invention provides a novel pyridinone compound having a trifluoromethyl group represented by the above formulas (1) to (7).
本発明は、式(1)〜式(7)で表されるトリフルオロメチル基を有する新規のピリジノン化合物、および当該ピリジノン化合物を式(8)〜式(13)で表されるヨウ化ピリジノン化合物中のヨウ素原子をトリフルオロメチル基で置換する反応、すなわちヨウ化ピリジノン化合物、ハロゲン化銅、(トリフルオロメチル)トリメチルシランおよび塩類を用いた反応によって合成するものである。 The present invention relates to a novel pyridinone compound having a trifluoromethyl group represented by formula (1) to formula (7), and the pyridinone compound represented by formula (8) to formula (13). It is synthesized by a reaction of substituting the iodine atom with a trifluoromethyl group, that is, a reaction using an iodinated pyridinone compound, copper halide, (trifluoromethyl) trimethylsilane and salts.
ヨウ化ピリジノン化合物は、1位がメチル基またはパラメトキシベンジル基で置換された1−置換ピリジン−2-オン骨格を含むものであって当該ピリジン−2−オン骨格をなす炭素のうち少なくとも1つがヨウ素原子と結合していればよいが、5−ヨード−1−(p−メトキシベンジル)ピリジン−2−オン、3−ヨード−1−メチルピリジン−2−オン、3,5−ジヨード−1−メチルピリジン−2−オン、3−ヨード−1−メチル−5,6,7,8−テトラハイドロキノリン−2−オン、3−ヨード−1−メチル−1,5,6,7−テトラハイドロシクロペンタ[b]ピリジン−2−オン、5,6−ジヒドロ−3−ヨード−1−(p−メトキシベンジル)−ベンゾ[h]キノリン−2−オンが好ましい。 The iodinated pyridinone compound includes a 1-substituted pyridin-2-one skeleton substituted at the 1-position with a methyl group or a paramethoxybenzyl group, and at least one of carbons constituting the pyridin-2-one skeleton is It may be bonded to an iodine atom, but 5-iodo-1- (p-methoxybenzyl) pyridin-2-one, 3-iodo-1-methylpyridin-2-one, 3,5-diiodo-1- Methylpyridin-2-one, 3-iodo-1-methyl-5,6,7,8-tetrahydroquinolin-2-one, 3-iodo-1-methyl-1,5,6,7-tetrahydrocyclo Penta [b] pyridin-2-one, 5,6-dihydro-3-iodo-1- (p-methoxybenzyl) -benzo [h] quinolin-2-one are preferred.
前記式(1)および式(2)で表わされるトリフルオロメチルピリジノン化合物は、ヨウ化ピリジノン化合物であってそれぞれ前記式(8)で表される5−ヨード−1−(p−メトキシベンジル)ピリジン−2−オン、前記式(9)で表される3−ヨード−1−メチルピリジン−2−オンから、さらに前記式(3)および式(4)で表わされるトリフルオロメチルピリジノン化合物は、ヨウ化ピリジノン化合物であって前記式(10)で表される3,5−ジヨード−1−メチルピリジン−2−オンから、並びに前記式(5)〜(7)で表わされるトリフルオロメチルピリジノン化合物は、ヨウ化ピリジノン化合物であってそれぞれ前記式(11)で表される3−ヨード−1−メチル−5,6,7,8−テトラハイドロキノリン−2−オン、前記式(12)で表される3−ヨード−1−メチル−1,5,6,7−テトラハイドロシクロペンタ[b]ピリジン−2−オン、前記式(13)で表される5,6−ジヒドロ−3−ヨード−1−(p−メトキシベンジル)−ベンゾ[h]キノリン−2−オンから、ヨウ素原子をトリフルオロメチル基で置換する本発明の反応により生成する。 The trifluoromethylpyridinone compounds represented by the above formulas (1) and (2) are iodinated pyridinone compounds, each of which is 5-iodo-1- (p-methoxybenzyl) represented by the above formula (8). From pyridine-2-one and 3-iodo-1-methylpyridin-2-one represented by the above formula (9), trifluoromethylpyridinone compounds represented by the above formula (3) and formula (4) are And a trifluoromethylpyridinone iodide compound from 3,5-diiodo-1-methylpyridin-2-one represented by the formula (10) and the formulas (5) to (7). The dinone compound is an iodinated pyridinone compound, which is 3-iodo-1-methyl-5,6,7,8-tetrahydroquinolin-2-one represented by the formula (11), respectively. 3-Iodo-1-methyl-1,5,6,7-tetrahydrocyclopenta [b] pyridin-2-one represented by formula (12), 5,6- represented by formula (13) It is produced from dihydro-3-iodo-1- (p-methoxybenzyl) -benzo [h] quinolin-2-one by the reaction of the present invention in which the iodine atom is substituted with a trifluoromethyl group.
本発明で用いることのできるハロゲン化銅としては、塩化銅(I)、臭化銅(I)、ヨウ化銅(I)が好ましく、高収率で目的物が得られることからヨウ化銅(I)がさらに好ましい。 As the copper halide that can be used in the present invention, copper (I) chloride, copper (I) bromide, and copper (I) iodide are preferable, and the target product can be obtained in a high yield. I) is more preferred.
本発明で用いる塩類とは、フッ化カリウム、フッ化セシウムおよびtert−ブトキシカリウムからなる群より選ばれる少なくとも1種の化合物である。フッ化カリウム、フッ化セシウム、tert−ブトキシカリウムは通常に市販されているフッ化カリウム、フッ化セシウム、tert−ブトキシカリウムを直接用いることができ、溶媒に均一に溶解した状態、あるいは一部が溶解した状態でも使用可能である。当該フッ化カリウムには、反応有機溶媒への溶解、分散性の面から微粉体で比表面積が大きいスプレードライ製法によるフッ化カリウムが含まれる。 The salts used in the present invention are at least one compound selected from the group consisting of potassium fluoride, cesium fluoride and tert-butoxypotassium. As potassium fluoride, cesium fluoride, and tert-butoxy potassium, commercially available potassium fluoride, cesium fluoride, and tert-butoxy potassium can be directly used. It can be used even in a dissolved state. The potassium fluoride includes potassium fluoride produced by a spray-drying method with a fine powder and a large specific surface area in terms of dissolution and dispersibility in a reaction organic solvent.
本発明で用いる溶媒は、非プロトン性の極性溶媒が好ましい。非プロトン性の極性溶媒の中でも、N,N−ジメチルホルムアミド、N−メチルピロリドン、N,N−ジメチルプロピレンウレア、N,N−ジメチルエチレンウレア、ジメチルスルホキシド、ヘキサメチルリン酸トリアミド、N,N−ジメチルアセトアミドが好ましく、これらは単独で使用し得るのみならず、2種類以上を混合して用いることも可能である。中でも入手が容易で、高収率で目的物が得られることからN,N−ジメチルホルムアミドが特に好ましい。 The solvent used in the present invention is preferably an aprotic polar solvent. Among aprotic polar solvents, N, N-dimethylformamide, N-methylpyrrolidone, N, N-dimethylpropyleneurea, N, N-dimethylethyleneurea, dimethylsulfoxide, hexamethylphosphoric triamide, N, N- Dimethylacetamide is preferable, and these can be used alone or in combination of two or more. Among these, N, N-dimethylformamide is particularly preferable because it is easily available and the target product can be obtained in high yield.
本発明の反応において、反応温度は0℃から溶媒の沸点までが好ましく、20℃から90℃の間がさらに好ましい。 In the reaction of the present invention, the reaction temperature is preferably from 0 ° C. to the boiling point of the solvent, more preferably from 20 ° C. to 90 ° C.
本発明で用いる試薬量は、ヨウ化ピリジノン化合物1モルに対して(トリフルオロメチル)トリメチルシランは1〜100モルが好ましく、1〜10モルがさらに好ましい。ハロゲン化銅はヨウ化ピリジノン化合物1モルに対して1〜100モルが好ましく、1〜10モルがさらに好ましい。フッ化カリウムもしくはtert−ブトキシカリウムはヨウ化ピリジノン化合物1モルに対して1〜100モルが好ましく、1〜10モルがさらに好ましい。溶媒量は特に制限するわけではないが、ヨウ化ピリジノン化合物1gに対して溶媒1〜100mLが好ましく、1〜20mLがさらに好ましい。 The amount of the reagent used in the present invention is preferably 1 to 100 moles, more preferably 1 to 10 moles of (trifluoromethyl) trimethylsilane with respect to 1 mole of the pyridinone iodide compound. 1-100 mol is preferable with respect to 1 mol of iodinated pyridinone compounds, and, as for copper halide, 1-10 mol is more preferable. 1-100 mol is preferable with respect to 1 mol of iodide pyridinone compounds, and, as for potassium fluoride or tert- butoxy potassium, 1-10 mol is more preferable. Although the amount of the solvent is not particularly limited, 1 to 100 mL of solvent is preferable and 1 to 20 mL is more preferable with respect to 1 g of the pyridinone iodide compound.
本発明で用いる試薬はあらゆる慣用の方法に従って導入することができ、溶媒、ハロゲン化銅、塩類および基質を先に混合し、最後に(トリフルオロメチル)トリメチルシランを供することが好ましい。 The reagent used in the present invention can be introduced according to any conventional method, and it is preferable to first mix the solvent, copper halide, salts and substrate, and finally provide (trifluoromethyl) trimethylsilane.
本発明のヨウ化ピリジノン化合物中のヨウ素原子をトリフルオロメチル基で置換する反応において、反応器は大気開放型の反応器、またはオートクレーブ等の密閉型の反応器のいずれも可能である。反応圧力は大気圧下、または加圧下のいずれも可能である。 In the reaction for replacing the iodine atom in the pyridinone iodide compound of the present invention with a trifluoromethyl group, the reactor can be either an open-air reactor or a sealed reactor such as an autoclave. The reaction pressure can be either atmospheric pressure or pressurized.
ヨウ化ピリジノン化合物のトリフルオロメチル化反応により得られたトリフルオロメチルピリジノン化合物は、一般的な手法によって反応液から単離および精製することができ、例えば反応液を水洗、溶剤抽出、乾燥、濃縮した後、蒸留精製またはシリカゲル、アルミナ等の吸着剤を用いたカラムクロマトグラフ法での精製、塩析、晶析、再結晶等が挙げられ、本発明の目的化合物であるトリフルオロメチルピリジノン化合物を得ることができる。 The trifluoromethylpyridinone compound obtained by the trifluoromethylation reaction of the iodinated pyridinone compound can be isolated and purified from the reaction solution by a general method. For example, the reaction solution is washed with water, solvent extracted, dried, After concentration, examples thereof include distillation purification, column chromatography using an adsorbent such as silica gel and alumina, salting out, crystallization, recrystallization and the like, and trifluoromethylpyridinone which is the target compound of the present invention A compound can be obtained.
カラムクロマトグラフ法による精製において、展開溶媒は、例えばヘキサン/酢酸エチル(0/100〜100/0(v/v))等を使用することができる。ヘキサンと酢酸エチルの混合溶媒を使用する際の混合比は任意の体積比(v/v)での混合溶媒を用いることができるが、目的物の単離が容易で高収率で目的物が得られることから、50/1〜1/1(v/v)が好ましい。 In the purification by column chromatography, for example, hexane / ethyl acetate (0/100 to 100/0 (v / v)) can be used as the developing solvent. As the mixing ratio when using a mixed solvent of hexane and ethyl acetate, a mixed solvent at an arbitrary volume ratio (v / v) can be used, but the target product can be easily isolated in a high yield. Since it is obtained, 50/1 to 1/1 (v / v) is preferable.
このようにして得られる本発明のトリフルオロメチルピリジノン化合物は、1H NMR、13C NMR、19F NMR、赤外吸収スペクトル法(IR)、元素分析法、ガスクロマトグラフ法(GC)等によって、その構造を特定することができる。 The trifluoromethylpyridinone compound of the present invention thus obtained can be obtained by 1 H NMR, 13 C NMR, 19 F NMR, infrared absorption spectroscopy (IR), elemental analysis, gas chromatography (GC), etc. The structure can be specified.
次に本発明を詳細に説明するが、本発明はこれらに限定されるものではない。 Next, the present invention will be described in detail, but the present invention is not limited thereto.
なお、分析用の機器として、NMR測定は日本電子株式会社製JNM−AL300、IR測定は日本分光株式会社(JASCO)製FT/IR−4100、融点測定はヤマト科学株式会社製融点測定器MP−21、元素分析はPerkin−Elmer社製CHNS/O Analyzer 2400を使用して分析した。 As an analytical instrument, NMR measurement is JNM-AL300 manufactured by JEOL Ltd., IR measurement is FT / IR-4100 manufactured by JASCO Corporation, and melting point measurement is melting point measuring instrument MP- manufactured by Yamato Scientific Co., Ltd. 21. Elemental analysis was performed using a Perkin-Elmer CHNS / O Analyzer 2400.
製造例1 (原料合成)
5−ヨードピリジン−2−オン(0.44g, 2.0mmol)、炭酸カリウム (0.30g, 2.2mmol)、p−メトキシベンジルクロリド(0.31g, 2.0mmol)をN,N−ジメチルホルムアミド10mL中、25度で一晩撹拌した。反応混合物に水20mLを加えた後、酢酸エチル(20mL×3回)で抽出した。酢酸エチル層を水(20mL×3回)で洗浄した後、無水硫酸マグネシウムで乾燥した。脱水剤をろ過後溶媒留去し、シリカゲルカラムクロマトグラフィー(充填剤 関東化学社製シリカゲル60球状(particle size63−210mm)、展開溶媒 ヘキサン:酢酸エチル=2:1〜1:1(v:v))で精製した。5−ヨード−1−(p−メトキシベンジル)ピリジン−2−オンを黄色油状物として0.56g(収率82%)得た。
Production Example 1 (raw material synthesis)
5-Iodopyridin-2-one (0.44 g, 2.0 mmol), potassium carbonate (0.30 g, 2.2 mmol) and p-methoxybenzyl chloride (0.31 g, 2.0 mmol) were mixed with N, N-dimethyl. Stir overnight at 25 degrees in 10 mL formamide. 20 mL of water was added to the reaction mixture, followed by extraction with ethyl acetate (20 mL × 3 times). The ethyl acetate layer was washed with water (20 mL × 3 times) and then dried over anhydrous magnesium sulfate. The solvent was distilled off after filtration of the dehydrating agent, and silica gel column chromatography (filler: Kanto Chemical Co., Ltd. silica gel 60 spheres (particle size 63-210 mm), developing solvent hexane: ethyl acetate = 2: 1 to 1: 1 (v: v) ). 0.56 g (yield 82%) of 5-iodo-1- (p-methoxybenzyl) pyridin-2-one was obtained as a yellow oil.
実施例1 式(1)化合物の合成
フッ化カリウム(0.15g, 2.6mmol)とヨウ化銅(0.50g, 2.6mmol) および5−ヨード−1−(p−メトキシベンジル)ピリジン−2−オン(0.34g, 1.0mmol)をN,N−ジメチルホルムアミド5mlで均一にし、続いて(トリフルオロメチル)トリメチルシラン (0.38 mL, 2.6 mmol)を加えた。反応溶液を80℃で6時間撹拌した。塩化アンモニウム水溶液10mLで希釈した後、酢酸エチル(20mL×3回)で抽出した。酢酸エチル層を無水硫酸マグネシウムで乾燥した後、溶媒を留去し、シリカゲルクロマトグラフィー(充填剤 関東化学社製シリカゲル60球状63−210mm、展開溶媒 ヘキサン:酢酸エチル=4:1〜1:1(v:v))で精製した。式(1)の5−トリフルオロメチル−1−(p−メトキシベンジル)ピリジン−2−オンを白色固体として0.19g得た(収率68%)。
Mp: 48 - 49 ℃ (Mpは融点を表わす。以下同じ)
1H NMR (300 MHz, CDCl3): δ3.81 (s, 3H), 5.01 (s, 2H), 6.65 (d, J=9.6 Hz, 1H), 6.90 (m, 2H), 7.27 (m, 2H), 7.42 (dd, J=9.6, 2.7 Hz, 1H), 7.63 (m, 1H).
13C NMR (75 Hz, CDCl3): δ52.0, 55.1, 109.6 (q, J=34.8 Hz), 114.3, 121.4, 123.2 (q, J=266.6 Hz), 127.1, 129.8, 134.8 (q, J=1.8 Hz), 136.5 (q, J=5.0 Hz), 159.7, 161.8.
19F NMR (282 Hz, CDCl3): δ-63.68 (s).
IR (neat, cm-1): ν3008, 2959, 2840, 1677, 1623, 1514, 1331, 1251, 1167, 1150, 1127.
Anal. Calcd for C14H12F3NO2: C, 59.37; H, 4.27; N, 4.95. Found: C, 58.93; H, 4.36; N, 4.90.
Example 1 Synthesis of Compound of Formula (1) Potassium fluoride (0.15 g, 2.6 mmol) and copper iodide (0.50 g, 2.6 mmol) and 5-iodo-1- (p-methoxybenzyl) pyridine- 2-one (0.34 g, 1.0 mmol) was homogenized with 5 ml of N, N-dimethylformamide, followed by the addition of (trifluoromethyl) trimethylsilane (0.38 mL, 2.6 mmol). The reaction solution was stirred at 80 ° C. for 6 hours. After diluting with 10 mL of aqueous ammonium chloride solution, the mixture was extracted with ethyl acetate (20 mL × 3 times). After the ethyl acetate layer was dried over anhydrous magnesium sulfate, the solvent was distilled off, and silica gel chromatography (filler, silica gel 60 spherical 63-210 mm, manufactured by Kanto Chemical Co., Inc., developing solvent hexane: ethyl acetate = 4: 1 to 1: 1 ( v: Purified in v)). 0.19 g of 5-trifluoromethyl-1- (p-methoxybenzyl) pyridin-2-one of the formula (1) was obtained as a white solid (yield 68%).
Mp: 48-49 ° C (Mp represents melting point; the same applies hereinafter)
1 H NMR (300 MHz, CDCl 3 ): δ3.81 (s, 3H), 5.01 (s, 2H), 6.65 (d, J = 9.6 Hz, 1H), 6.90 (m, 2H), 7.27 (m, 2H), 7.42 (dd, J = 9.6, 2.7 Hz, 1H), 7.63 (m, 1H).
13 C NMR (75 Hz, CDCl 3 ): δ52.0, 55.1, 109.6 (q, J = 34.8 Hz), 114.3, 121.4, 123.2 (q, J = 266.6 Hz), 127.1, 129.8, 134.8 (q, J = 1.8 Hz), 136.5 (q, J = 5.0 Hz), 159.7, 161.8.
19 F NMR (282 Hz, CDCl 3 ): δ-63.68 (s).
IR (neat, cm -1 ): ν3008, 2959, 2840, 1677, 1623, 1514, 1331, 1251, 1167, 1150, 1127.
Anal. Calcd for C 14 H 12 F 3 NO 2 : C, 59.37; H, 4.27; N, 4.95. Found: C, 58.93; H, 4.36; N, 4.90.
実施例2
ヨウ化銅(I)を臭化銅(I)に換えた以外は実施例1と同じ条件に付したところ、式(1)の5−トリフルオロメチル−1−(p−メトキシベンジル)ピリジン−2−オンを収率30%で得た。
Example 2
Except that the copper (I) iodide was replaced with copper (I) bromide, the same conditions as in Example 1 were applied. As a result, 5-trifluoromethyl-1- (p-methoxybenzyl) pyridine of formula (1) 2-one was obtained in 30% yield.
実施例3
ヨウ化銅(I)を塩化銅(I)に換えた以外は実施例1と同じ条件に付したところ、式(1)の5−トリフルオロメチル−1−(p−メトキシベンジル)ピリジン−2−オンを収率29%で得た。
Example 3
Except that the copper (I) iodide was replaced with copper (I) chloride, the same conditions as in Example 1 were applied. As a result, 5-trifluoromethyl-1- (p-methoxybenzyl) pyridine-2 represented by the formula (1) was obtained. -On was obtained in 29% yield.
実施例4
フッ化カリウムをtert−ブトキシカリウムに換えた以外は実施例1と同じ条件に付したところ、式(1)の5−トリフルオロメチル−1−(p−メトキシベンジル)ピリジン−2−オンを収率70%で得た。
Example 4
Except that potassium fluoride was replaced with tert-butoxypotassium, the same conditions as in Example 1 were applied. As a result, 5-trifluoromethyl-1- (p-methoxybenzyl) pyridin-2-one of formula (1) was recovered. Obtained at a rate of 70%.
実施例5
フッ化カリウムをフッ化セシウムに換えた以外は実施例1と同じ条件に付したところ、式(1)の5−トリフルオロメチル−1−(p−メトキシベンジル)ピリジン−2−オンを収率82%で得た。
Example 5
Except for replacing potassium fluoride with cesium fluoride, the same conditions as in Example 1 were applied. As a result, 5-trifluoromethyl-1- (p-methoxybenzyl) pyridin-2-one of formula (1) was obtained in a yield. Obtained at 82%.
実施例6 式(2)化合物の合成
基質を3−ヨード−1−メチルピリジン−2−オンを用いた以外は実施例1と同じ条件に付したところ、式(2)の3−(トリフルオロメチル)−1−メチルピリジン−2−オンを白色固体(収率87%)として得た。
Mp: 93 - 94 ℃.
1H NMR (300 MHz, CDCl3): δ3.62 (s, 3H), 6.25 (t, J=7.2 Hz, 1H), 7.55 (d, J=6.9 Hz, 1H), 7.76 (d, J=6.9 Hz, 1H).
13C NMR (75 Hz, CDCl3): δ37.6, 103.8, 119.9 (q, J=31.0 Hz), 122.7 (q, J=271.0 Hz), 138.8 (q, J=5.0 Hz), 142.4, 158.7.
19F NMR (282 Hz, CDCl3): δ67.35 (s).
IR (KBr, cm-1): ν3087, 3053, 3013, 1650, 1569, 1467, 1316, 1126, 1079, 880, 771. Anal. Calcd for C7H6F3NO: C, 47.47; H, 3.41; N, 7.91. Found: C, 47.52; H, 3.18; N, 7.88.
Example 6 Synthesis of Compound of Formula (2) When 3-iodo-1-methylpyridin-2-one was used as a substrate under the same conditions as in Example 1, 3- (trifluoro) of formula (2) was used. Methyl) -1-methylpyridin-2-one was obtained as a white solid (87% yield).
Mp: 93-94 ° C.
1 H NMR (300 MHz, CDCl 3 ): δ3.62 (s, 3H), 6.25 (t, J = 7.2 Hz, 1H), 7.55 (d, J = 6.9 Hz, 1H), 7.76 (d, J = (6.9 Hz, 1H).
13 C NMR (75 Hz, CDCl 3 ): δ37.6, 103.8, 119.9 (q, J = 31.0 Hz), 122.7 (q, J = 271.0 Hz), 138.8 (q, J = 5.0 Hz), 142.4, 158.7 .
19 F NMR (282 Hz, CDCl 3 ): δ67.35 (s).
IR (KBr, cm -1 ): ν3087, 3053, 3013, 1650, 1569, 1467, 1316, 1126, 1079, 880, 771. Anal.Calcd for C 7 H 6 F 3 NO: C, 47.47; H, 3.41 ; N, 7.91. Found: C, 47.52; H, 3.18; N, 7.88.
実施例7 式(3)化合物および式(4)化合物の合成
アルゴン置換した反応容器内で、フッ化カリウム(0.15g, 2.6mmol)とヨウ化銅(0.50g, 2.6mmol) および3,5−ジヨード−1−メチルピリジン−2−オン(0.18g, 0.5mmol)をN,N−ジメチルホルムアミド5mlで均一にし、続いて(トリフルオロメチル)トリメチルシラン (0.38 mL, 2.6 mmol)を加えた。反応溶液を室温で48時間撹拌した。塩化アンモニウム水溶液10mLで希釈した後、酢酸エチル(10mL×3回)で抽出した。酢酸エチル層を無水硫酸マグネシウムで乾燥した後、溶媒を留去し、シリカゲルクロマトグラフィー(充填剤 関東化学社製シリカゲル60球状63−210mm、展開溶媒 ヘキサン:酢酸エチル=8:1〜2:1(v:v))で精製した。式(3)の1−メチル−3,5−ビス(トリフルオロメチル)ピリジン−2−オンを白色固体(収率35%)および式(4)の5−ヨード−1−メチル−3−(トリフルオロメチル)ピリジン−2−オンを白色固体(収率57%)としてそれぞれ得た。
Example 7 Synthesis of compound of formula (3) and compound of formula (4) In a reaction vessel purged with argon, potassium fluoride (0.15 g, 2.6 mmol) and copper iodide (0.50 g, 2.6 mmol) and 3,5-Diiodo-1-methylpyridin-2-one (0.18 g, 0.5 mmol) was homogenized with 5 ml of N, N-dimethylformamide followed by (trifluoromethyl) trimethylsilane (0.38 mL, 2.6 mmol) was added. The reaction solution was stirred at room temperature for 48 hours. After diluting with 10 mL of an aqueous ammonium chloride solution, extraction was performed with ethyl acetate (10 mL × 3 times). After the ethyl acetate layer was dried over anhydrous magnesium sulfate, the solvent was distilled off, and silica gel chromatography (filler, silica gel 60 spherical 63-210 mm, manufactured by Kanto Chemical Co., Inc., developing solvent hexane: ethyl acetate = 8: 1 to 2: 1 ( v: Purified in v)). 1-methyl-3,5-bis (trifluoromethyl) pyridin-2-one of formula (3) was converted to white solid (35% yield) and 5-iodo-1-methyl-3- ( Trifluoromethyl) pyridin-2-one was obtained as a white solid (57% yield), respectively.
[式(3)化合物データ]
Mp: 76 - 77 ℃.
1H NMR (300 MHz, CDCl3): δ3.66 (s, 3H), 7.89 (s, 1H), 7.92 (s, 1H).
13C NMR (75 Hz, CDCl3): δ38.4, 107.9 (q, J=32.0 Hz), 120.7 (q, J=31.0 Hz), 121.9 (q, J=271.0 Hz), 122.6 (q, J=269.8 Hz), 134.9 (m), 141.6 (q, J=5.0 Hz), 158.0.
19F NMR (282 Hz, CDCl3): δ62.84 (s), 67.27 (s).
IR (KBr, cm-1): ν3054, 1636, 1580, 1505, 1417, 1303, 1207, 1117, 892, 752, 686.
Anal. Calcd for C8H5F6NO: C, 39.20; H, 2.06; N, 5.71. Found: C, 38.72; H, 1.99; N, 5.64.
[Formula (3) compound data]
Mp: 76-77 ° C.
1 H NMR (300 MHz, CDCl 3 ): δ3.66 (s, 3H), 7.89 (s, 1H), 7.92 (s, 1H).
13 C NMR (75 Hz, CDCl 3 ): δ38.4, 107.9 (q, J = 32.0 Hz), 120.7 (q, J = 31.0 Hz), 121.9 (q, J = 271.0 Hz), 122.6 (q, J = 269.8 Hz), 134.9 (m), 141.6 (q, J = 5.0 Hz), 158.0.
19 F NMR (282 Hz, CDCl 3 ): δ62.84 (s), 67.27 (s).
IR (KBr, cm -1 ): ν3054, 1636, 1580, 1505, 1417, 1303, 1207, 1117, 892, 752, 686.
Anal. Calcd for C 8 H 5 F 6 NO: C, 39.20; H, 2.06; N, 5.71. Found: C, 38.72; H, 1.99; N, 5.64.
[式(4)化合物データ]
Mp: 135 - 136 ℃.
1H NMR (300 MHz, CDCl3): δ3.59 (s, 3H), 7.77 (s, 1H), 7.84 (s, 1H).
13C NMR (75 Hz, CDCl3): δ37.7, 60.7, 121.6 (q, J=272.3 Hz), 121.7 (q, J=31.0 Hz), 146.1 (q, J=5.0 Hz), 147.2, 157.3.
19F NMR (282 Hz, CDCl3): δ67.41 (s).
IR (KBr, cm-1): ν 3046, 1660, 1593, 1556, 1422, 1303, 1175, 1129, 919, 679.
Anal. Calcd for C7H5F3INO: C, 27.75; H, 1.66; N, 4.62. Found: C, 27.66; H, 1.74; N, 4.48.
[Formula (4) compound data]
Mp: 135-136 ° C.
1 H NMR (300 MHz, CDCl 3 ): δ3.59 (s, 3H), 7.77 (s, 1H), 7.84 (s, 1H).
13 C NMR (75 Hz, CDCl 3 ): δ37.7, 60.7, 121.6 (q, J = 272.3 Hz), 121.7 (q, J = 31.0 Hz), 146.1 (q, J = 5.0 Hz), 147.2, 157.3 .
19 F NMR (282 Hz, CDCl 3 ): δ67.41 (s).
IR (KBr, cm -1 ): ν 3046, 1660, 1593, 1556, 1422, 1303, 1175, 1129, 919, 679.
Anal.Calcd for C 7 H 5 F 3 INO: C, 27.75; H, 1.66; N, 4.62. Found: C, 27.66; H, 1.74; N, 4.48.
実施例8 式(5)化合物の合成
基質を3−ヨード−1−メチル−5,6,7,8−テトラハイドロキノリン−2−オンを用いた以外は実施例1と同じ条件に付したところ、式(5)の1−メチル−3−トリフルオロメチル−5,6,7,8−テトラハイドロキノリン−2−オンを白色固体(収率98%)として得た。
Mp: 111 - 112 ℃.
1H NMR (300 MHz, CDCl3): δ1.75 (m, 2H), 1.89 (m, 2H), 2.56 (t, J=6.0 Hz, 2H), 2.68 (t, J=5.7 Hz, 2H), 3.53 (s, 3H), 7.48 (s, 1H).
13C NMR (75 Hz, CDCl3): δ21.2, 21.8, 27.0, 27.6, 30.0, 116.1 (q, J=30.4 Hz), 123.0 (q, J=270.4 Hz), 139.6 (q, J=5.0 Hz), 148.6, 158.7.
19F NMR (282 Hz, CDCl3): δ66.92 (s).
IR (KBr, cm-1): ν 3037, 2948, 2874, 1666, 1606, 1557, 1427, 1323, 1174, 1133, 1100, 1071, 983, 944.
Anal. Calcd for C11H12F3NO: C, 57.14; H, 5.23; N, 6.06. Found: C, 57.20; H, 4.99; N, 6.07.
Example 8 Synthesis of compound of formula (5) The same conditions as in Example 1 were used except that 3-iodo-1-methyl-5,6,7,8-tetrahydroquinolin-2-one was used as the substrate. 1-methyl-3-trifluoromethyl-5,6,7,8-tetrahydroquinolin-2-one of formula (5) was obtained as a white solid (yield 98%).
Mp: 111-112 ° C.
1 H NMR (300 MHz, CDCl 3 ): δ1.75 (m, 2H), 1.89 (m, 2H), 2.56 (t, J = 6.0 Hz, 2H), 2.68 (t, J = 5.7 Hz, 2H) , 3.53 (s, 3H), 7.48 (s, 1H).
13 C NMR (75 Hz, CDCl 3 ): δ21.2, 21.8, 27.0, 27.6, 30.0, 116.1 (q, J = 30.4 Hz), 123.0 (q, J = 270.4 Hz), 139.6 (q, J = 5.0 Hz), 148.6, 158.7.
19 F NMR (282 Hz, CDCl 3 ): δ66.92 (s).
IR (KBr, cm -1 ): ν 3037, 2948, 2874, 1666, 1606, 1557, 1427, 1323, 1174, 1133, 1100, 1071, 983, 944.
Anal. Calcd for C 11 H 12 F 3 NO: C, 57.14; H, 5.23; N, 6.06. Found: C, 57.20; H, 4.99; N, 6.07.
実施例9 式(6)化合物の合成
基質を3−ヨード−1−メチル−1,5,6,7−テトラハイドロシクロペンタ[b]ピリジン−2−オンを用いた以外は実施例1と同じ条件に付したところ、式(6)の1−メチル−3−(トリフルオロメチル)−1,5,6,7−テトラハイドロシクロペンタ[b] ピリジン−2−オンを白色固体として得た(収率99%)。
Mp: 143 - 144 ℃.
1H NMR (300 MHz, CDCl3): δ2.20 (quint., J=7.5 Hz, 2H), 2.83 (t, J=7.5 Hz, 2H), 2.97 (m, 2H), 3.54 (s, 3H), 7.65 (s, 1H).
13C NMR (75 Hz, CDCl3): δ22.2, 29.8, 32.5, 115.8 (q, J=29.2 Hz), 116.9, 123.2 (q, J=271.0 Hz), 135.4 (q, J=5.0 Hz), 155.4, 159.2.
19F NMR (282 Hz, CDCl3): δ66.97 (s).
IR (KBr, cm-1): ν3021, 2918, 2864, 1642, 1577, 1530, 1433, 1231, 791, 753.
Anal. Calcd for C10H10F3NO: C, 55.30; H, 4.64; N, 6.45. Found: C,55.00; H,4.43; N,5.96.
Example 9 Synthesis of Compound of Formula (6) Same as Example 1 except that 3-iodo-1-methyl-1,5,6,7-tetrahydrocyclopenta [b] pyridin-2-one was used as the substrate. When subjected to conditions, 1-methyl-3- (trifluoromethyl) -1,5,6,7-tetrahydrocyclopenta [b] pyridin-2-one of formula (6) was obtained as a white solid ( Yield 99%).
Mp: 143-144 ° C.
1 H NMR (300 MHz, CDCl 3 ): δ2.20 (quint., J = 7.5 Hz, 2H), 2.83 (t, J = 7.5 Hz, 2H), 2.97 (m, 2H), 3.54 (s, 3H ), 7.65 (s, 1H).
13 C NMR (75 Hz, CDCl 3 ): δ22.2, 29.8, 32.5, 115.8 (q, J = 29.2 Hz), 116.9, 123.2 (q, J = 271.0 Hz), 135.4 (q, J = 5.0 Hz) , 155.4, 159.2.
19 F NMR (282 Hz, CDCl 3 ): δ66.97 (s).
IR (KBr, cm -1 ): ν3021, 2918, 2864, 1642, 1577, 1530, 1433, 1231, 791, 753.
Anal. Calcd for C 10 H 10 F 3 NO: C, 55.30; H, 4.64; N, 6.45. Found: C, 55.00; H, 4.43; N, 5.96.
実施例10 式(7)化合物の合成
基質を5,6−ジヒドロ−3−ヨード−1−(p−メトキシベンジル)−ベンゾ[h]キノリン−2−オンを用いた以外は実施例1と同じ条件に付したところ、式(7)の5,6−ジヒドロ−1−(p−メトキシベンジル)−3−(トリフルオロメチル)ベンゾ[h]キノリン−2−オンを高粘性黄色油状物として得た(収率98%)。
1H NMR (300 MHz, CDCl3): δ2.92 (m, 4H), 3.80 (s, 3H), 5.57 (s, 2H), 6.90 (d, J=8.7 Hz, 2H), 7.25 (m, 1H), 7.36 (m, 2H), 7.45 (d, J=8.7 Hz, 2H), 7.68 (s, 1H), 8.27 (m, 1H).
13C NMR (75 Hz, CDCl3): δ26.5, 27.9, 55.1, 67.4, 111.1 (q, J=32.2 Hz), 113.7, 123.3 (q, J=271.0 Hz), 123.5, 125.4, 127.0, 127.9, 129.1, 129.2, 129.3, 133.4, 136.3 (q, J=4.4 Hz), 138.5, 152.8, 158.8(q, J=1.9 Hz).
19F NMR (282 Hz, CDCl3): δ64.21 (s).
IR (KBr, cm-1): ν3008, 2940, 2839, 1614, 1515, 1439, 1304, 1274, 1248, 1135, 1078.
Anal. Calcd for C22H18F3NO2: C, 68.57; H, 4.71; N, 3.63. Found: C, 68.39; H, 4.78; N, 3.54.
Example 10 Synthesis of Compound of Formula (7) Same as Example 1 except that 5,6-dihydro-3-iodo-1- (p-methoxybenzyl) -benzo [h] quinolin-2-one was used as the substrate. When subjected to conditions, 5,6-dihydro-1- (p-methoxybenzyl) -3- (trifluoromethyl) benzo [h] quinolin-2-one of formula (7) was obtained as a highly viscous yellow oil. (Yield 98%).
1 H NMR (300 MHz, CDCl 3 ): δ2.92 (m, 4H), 3.80 (s, 3H), 5.57 (s, 2H), 6.90 (d, J = 8.7 Hz, 2H), 7.25 (m, 1H), 7.36 (m, 2H), 7.45 (d, J = 8.7 Hz, 2H), 7.68 (s, 1H), 8.27 (m, 1H).
13 C NMR (75 Hz, CDCl 3 ): δ26.5, 27.9, 55.1, 67.4, 111.1 (q, J = 32.2 Hz), 113.7, 123.3 (q, J = 271.0 Hz), 123.5, 125.4, 127.0, 127.9 , 129.1, 129.2, 129.3, 133.4, 136.3 (q, J = 4.4 Hz), 138.5, 152.8, 158.8 (q, J = 1.9 Hz).
19 F NMR (282 Hz, CDCl 3 ): δ64.21 (s).
IR (KBr, cm -1 ): ν3008, 2940, 2839, 1614, 1515, 1439, 1304, 1274, 1248, 1135, 1078.
Anal. Calcd for C 22 H 18 F 3 NO 2 : C, 68.57; H, 4.71; N, 3.63. Found: C, 68.39; H, 4.78; N, 3.54.
本発明は、新規のトリフルオロメチル基を有するピリジノン化合物を見出したものであり、さらにヨウ化ピリジノン化合物、ハロゲン化銅、塩類、および(トリフルオロメチル)トリメチルシランを用いることによって合成できることを見出した。トリフルオロメチル基を有するピリジノン化合物は優れた医農薬中間体および機能性材料原料であり、本発明は簡便かつ効率的に合成できる新規トリフルオロメチルピリジノン化合物を提供するものであり、工業的にも有用である。 This invention discovered the pyridinone compound which has a novel trifluoromethyl group, and also discovered that it can synthesize | combine by using an iodinated pyridinone compound, copper halide, salts, and (trifluoromethyl) trimethylsilane. . Pyridinone compounds having a trifluoromethyl group are excellent raw materials for medical and agrochemical intermediates and functional materials, and the present invention provides a novel trifluoromethylpyridinone compound that can be synthesized simply and efficiently. Is also useful.
Claims (2)
下記式(8)〜(13)で表されるヨウ化ピリジノン化合物、ハロゲン化銅、(トリフルオロメチル)トリメチルシラン、およびフッ化カリウム、フッ化セシウムおよびtert−ブトキシカリウムからなる群より選ばれる少なくとも1種の塩類を反応させることを特徴とする前記式(1)〜(7)で表わされるトリフルオロメチルピリジノン化合物の製造方法。
At least selected from the group consisting of a pyridinone iodide compound represented by the following formulas (8) to (13), copper halide, (trifluoromethyl) trimethylsilane, and potassium fluoride, cesium fluoride and tert-butoxypotassium. A method for producing a trifluoromethylpyridinone compound represented by the above formulas (1) to (7), wherein one kind of salt is reacted.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012048888A JP5924984B2 (en) | 2012-03-06 | 2012-03-06 | Trifluoromethylpyridinone compound and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012048888A JP5924984B2 (en) | 2012-03-06 | 2012-03-06 | Trifluoromethylpyridinone compound and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013184893A JP2013184893A (en) | 2013-09-19 |
JP5924984B2 true JP5924984B2 (en) | 2016-05-25 |
Family
ID=49386656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012048888A Active JP5924984B2 (en) | 2012-03-06 | 2012-03-06 | Trifluoromethylpyridinone compound and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5924984B2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100486576C (en) * | 2002-02-14 | 2009-05-13 | 法玛西雅公司 | Substituted pyridinones as modulators of P38MAP kinase |
MX2008013999A (en) * | 2006-11-06 | 2008-11-12 | Sagami Chem Res | Reaction reagent for trifluoromethylation. |
ES2442847T3 (en) * | 2007-04-18 | 2014-02-13 | Amgen, Inc | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
CN101848893B (en) * | 2007-09-14 | 2012-06-06 | 奥梅-杨森制药有限公司 | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
BRPI0820400A2 (en) * | 2007-11-20 | 2015-05-19 | Sumitomo Chemical Co | Pyridine compound, pesticide composition and pest control method. |
JP5219086B2 (en) * | 2009-03-24 | 2013-06-26 | 国立大学法人九州大学 | Process for producing trifluoromethylarenes |
AU2010252451B2 (en) * | 2009-05-25 | 2014-04-03 | Central South University | 1-(substituted benzyl)-5-trifluoromethyl-2-(1H) pyridone compounds and their salts, their preparation methods and use thereof |
-
2012
- 2012-03-06 JP JP2012048888A patent/JP5924984B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013184893A (en) | 2013-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2850337C (en) | Method for producing 4,4-difluoro-3,4-dihydroisoquinoline derivatives | |
KR100551925B1 (en) | Process for the preparation of 2-halobenzoic acids | |
CN104829672A (en) | Synthesis method of drug intermediate | |
US20170029361A1 (en) | Halogenated aniline and method for producing same | |
EP3088391B1 (en) | Method for producing benzyl ester 2-aminonicotinate derivative | |
JP2019081748A (en) | Method for producing halogen compound | |
JP5924984B2 (en) | Trifluoromethylpyridinone compound and method for producing the same | |
CN105007734B (en) | The method for preparing 4 amino, 5 fluorine, 3 chlorine 6 (substituted) picolinic acid ester | |
TWI403504B (en) | Method for producing 2-haloimidazole compound | |
JP5793983B2 (en) | Method for producing pyrazole compound | |
JP6968868B2 (en) | Methods for Producing Fluoroalkyl Nitriles and Corresponding Fluoroalkyl Tetrazoles | |
JP7440208B2 (en) | Alkylation method | |
JP2010077089A (en) | Method for producing halopyrazinecarboxamide compound | |
JP3805788B2 (en) | Method for producing cyanopyridines | |
CN109369456A (en) | A kind of preparation method of 2,4- dicyano trifluomethoxybenzene | |
CN104136422A (en) | Compound, method for producing compound, and method for purifying compound | |
JP4552939B2 (en) | 2-substituted-3- (4-tetrahydropyranyl) -3-oxopropanoic acid ester and process for producing the same | |
JP5790195B2 (en) | Method for producing pyrazole compound | |
WO2021193432A1 (en) | Method for producing production intermediate of cyclaniliprole | |
JP2022090710A (en) | Production method of chloromethyl benzoate derivative | |
CN104262295A (en) | Synthesis method of epoxy chalcone and derivatives thereof | |
CN117098744A (en) | Method for producing organofluorine compound | |
JP5748210B2 (en) | Method for producing heterocyclic compound | |
JPH05201981A (en) | Production of 2-amino-3-nitro-5-halogenopyridine compound | |
JPH01305041A (en) | Production of fluorohaloalkane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150305 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150305 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20151015 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151221 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160210 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20160210 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20160322 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160412 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160419 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5924984 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |